Publication:
Radiopeptide therapy with cholecystokinin-B/gastrin receptor ligands labeled with Auger/conversion electron-versus alpha- or conventional beta-emitters.

dc.bibliographiccitation.issue5
dc.bibliographiccitation.journalJournal of Nuclear Medicine
dc.bibliographiccitation.volume41
dc.contributor.authorBehr, T. M.
dc.contributor.authorBehe, M.
dc.contributor.authorAngerstein, C.
dc.contributor.authorStabin, M. G.
dc.contributor.authorApostolidis, C.
dc.contributor.authorMolinet, R.
dc.contributor.authorKoch, L.
dc.contributor.authorRoesch, F.
dc.contributor.authorBecker, W.
dc.date.accessioned2018-11-07T10:54:50Z
dc.date.available2018-11-07T10:54:50Z
dc.date.issued2000
dc.format.extent112P
dc.identifier.isi000089892400442
dc.identifier.urihttps://resolver.sub.uni-goettingen.de/purl?gro-2/49654
dc.notes.statuszu prüfen
dc.notes.submitterNajko
dc.publisherSoc Nuclear Medicine Inc
dc.publisher.placeReston
dc.relation.issn0161-5505
dc.titleRadiopeptide therapy with cholecystokinin-B/gastrin receptor ligands labeled with Auger/conversion electron-versus alpha- or conventional beta-emitters.
dc.typeconference_abstract
dc.type.internalPublicationyes
dc.type.peerReviewedyes
dc.type.statuspublished
dspace.entity.typePublication

Files

Collections